2024-10-26 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**Company Overview:** UnitedHealth Group Inc. is a leading US-based health insurance company, offering a broad range of health and well-being products and services.

**1. Performance vs. S&P 500 (VOO):**

- **Cumulative Return (UNH):** 283.04%
- **Cumulative Return (VOO):** 135.48%
- **Divergence:** 147.56 (Relative Divergence: 59.85%)

UNH has significantly outperformed the S&P 500 (VOO) over the period analyzed, with a cumulative return exceeding that of VOO by almost 150%. This strong performance places UNH within the top 60% of its historical divergence range compared to VOO.

**2. Recent Price Movement:**

- **Closing Price:** $560.81 (Last Market: $564.39)
- **5-Day Moving Average:** $567.28
- **20-Day Moving Average:** $580.68
- **60-Day Moving Average:** $581.47

The current price is slightly below its 5-day moving average, indicating potential short-term weakness. However, it is still above its 20- and 60-day moving averages, suggesting a longer-term positive trend.

**3. Technical Indicators:**

- **RSI:** 37.23
- **PPO:** -0.47
- **Delta_Previous_Relative_Divergence:** -4.93 (Negative) - Short-term downtrend.
- **Expected Return:** 53.72% - Long-term (2+ years) expected return over S&P 500, assuming consistent investment.

UNH currently displays a neutral to slightly bearish technical profile. While the RSI indicates it's approaching oversold territory, the negative Delta_Previous_Relative_Divergence suggests short-term downward pressure. However, the high expected return remains a positive factor for long-term investors.

**4. Recent Earnings & Outlook:**

| Date        | EPS    | Revenue      |
|-------------|--------|--------------|
| 2024-08-09 | 4.58   | $98.86 B    |
| 2024-05-09 | -1.53  | $99.80 B    |
| 2023-11-06 | 6.31   | $92.36 B    |
| 2023-08-02 | 5.89   | $92.90 B    |
| 2024-08-09 | 5.89   | $92.90 B    |

The most recent earnings for the quarter ending August 09, 2024, were reported at $4.58 EPS and $98.86 Billion in revenue.  While further analysis of specific earnings calls and analyst estimates is needed for a comprehensive assessment, the recent performance suggests strong growth potential for the company.

**5. News & Recent Issues:**

* **Recent Earnings News:** There are no specific earnings news articles published within the last two days. 
* **Analyst Opinions:** Most analysts maintain a positive outlook on UNH due to its strong market position, diversified revenue streams, and consistent growth. Recent performance highlights include their expansion in the Medicare Advantage market and continued focus on healthcare innovation.
* **Market Outlook:** The healthcare industry is generally considered to be a stable and defensive sector, making UNH a potentially attractive investment, particularly in times of economic uncertainty.  
* **Recent Market Trends:**  UNH's stock price has seen some volatility in recent weeks, but analysts remain confident in its long-term growth potential.

**6. Overall Analysis:**

- **Positive:** UNH's performance significantly outpaces the S&P 500.  Despite a slightly bearish technical outlook in the short term, a strong expected return and consistent growth potential favor long-term investment. 
- **Neutral:** Current market sentiment is neutral to slightly bullish for UNH, with analysts generally positive on its long-term growth prospects.
- **Negative:** Short-term downward pressure is indicated by technical indicators. However, this does not necessarily diminish the long-term investment appeal of UNH. 

**7. Recommendation:**

Given UNH's strong performance, diversified revenue streams, and positive growth prospects, the stock remains a solid investment option. However, the current short-term technical outlook suggests a potential dip in the near future.  Investors with a long-term horizon might consider a gradual accumulation strategy, averaging into the stock if it sees a price correction.  It is recommended to closely monitor technical indicators and news releases before making any investment decisions. 
